findmyKOL
Clinical trialNCT05524532CompletedPhase 3Interventional

Effects of Immulina TM Supplements With PASC Patients

SponsorUniversity of Mississippi Medical CenterEnrollment101Post Acute COVID-19 Syndrome
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Gailen D Marshall, Jr., MD, PhD

    University of Mississippi Medical Center

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico
  • University of Puerto Rico

    San Juan, Puerto Rico, Puerto Rico

United States
  • University of Hawaii

    Honolulu, Hawaii, United States

  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana, United States

  • Louisiana State University

    New Orleans, Louisiana, United States

  • Mainehealth

    Portland, Maine, United States

  • University of Mississippi Medical Center

    Jackson, Mississippi, United States

  • University of Nebraska Medical Center

    Omaha, Nebraska, United States

  • University of Oklahoma

    Oklahoma City, Oklahoma, United States

  • West Virginia University

    Morgantown, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Jul 2023
Primary completion
29 Jul 2025
Completion
29 Jul 2025
Last update posted
14 Aug 2025
Registered enrollment
101
Registry id
NCT05524532

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.